
|Podcasts|January 18, 2022
Emerging HIFU technology shows promise in men with prostate cancer
Author(s)Urology Times staff
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jennifer Linehan, MD. She discusses the role that high-intensity focused ultrasound (HIFU) has played among other minimally invasive and robotic technologies to mitigate the side effects and complications of treatment for prostate cancer, compared toe other treatment options. Linehan is an associate professor of urology and urologic oncology at the John Wayne Cancer Institute in Santa Monica, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
2
Lymph Node Dissection Following Systemic Therapy in MIBC
3
Enzalutamide plus talazoparib demonstrates clinical activity in mHSPC
4
Unmet needs and emerging solutions in MRI-guided prostate cancer care
5













